CMFRI signs MoU to launch product from seaweeds to combat fatty liver disease Metro Vaartha dated 20th December 2022
CMFRI Repository
View Archive InfoField | Value | |
Relation |
http://eprints.cmfri.org.in/16560/
https://www.english.metrovaartha.com/news/80347/cmfri-signs-mou-to-launch-product-from-seaweeds-to-combat-fatty-liver-disease- |
|
Title |
CMFRI signs MoU to launch product from seaweeds to combat fatty liver disease Metro Vaartha dated 20th December 2022
|
|
Creator |
CMFRI, Library
|
|
Subject |
CMFRI News Clippings
|
|
Description |
The Central Marine Fisheries Research Institute (CMFRI) has signed an MoU for the production of Cadalmin LivCure extract, a patent-protected nutraceutical product from seaweeds, to combat non-alcoholic fatty liver disease (NAFLD). A Memorandum of Understanding (MoU) was inked with Emineotech, a private limited company dealing with health products, for commercial production and marketing of the product.
|
|
Publisher |
Metro Vaartha
|
|
Date |
2022
|
|
Type |
Article
PeerReviewed |
|
Format |
text
|
|
Language |
en
|
|
Identifier |
http://eprints.cmfri.org.in/16560/1/Metro%20Vaartha_20-12-2022.pdf
CMFRI, Library (2022) CMFRI signs MoU to launch product from seaweeds to combat fatty liver disease Metro Vaartha dated 20th December 2022. Metro Vaartha. |
|